RxSight, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
RxSight, Inc. (RXST) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $7.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-05
- RxSight, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $7.46M, a 12.66% decline year-over-year.
- RxSight, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $7.95M, a 11.27% increase year-over-year.
- RxSight, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $8.11M, a 23.75% increase year-over-year.
- RxSight, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $8.55M, a 40.00% increase year-over-year.
- RxSight, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $31.61M, a 28.32% increase from fiscal 2024.
- RxSight, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $24.64M, a 56.45% increase from fiscal 2023.
- RxSight, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $15.75M, a 38.16% increase from fiscal 2022.
- RxSight, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $11.40M, a 50.46% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.46M 10-Q · filed 2026-08-05 | $15.41M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $7.95M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $31.61M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $8.11M 10-Q · filed 2025-11-05 | $16.66M derived: sum of 2 quarters · filed 2026-08-05 | $23.80M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-06-30 | $8.55M 10-Q · filed 2026-08-05 | $15.69M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $7.14M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $24.64M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $6.55M 10-Q · filed 2025-11-05 | $12.66M derived: sum of 2 quarters · filed 2025-11-05 | $17.35M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $6.11M 10-Q · filed 2025-11-05 | $10.80M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $4.70M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $15.75M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $4.07M 10-Q · filed 2024-11-07 | $8.03M derived: sum of 2 quarters · filed 2024-11-07 | $11.32M derived: sum of 3 quarters · filed 2024-11-07 | |
| 2023-06-30 | $3.96M 10-Q · filed 2024-11-07 | $7.25M derived: sum of 2 quarters · filed 2024-11-07 | ||
| 2023-03-31 | $3.29M 10-Q · filed 2024-11-07 | |||
| 2022-12-31 | $11.40M 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $2.88M 10-Q · filed 2023-11-09 | $5.79M derived: sum of 2 quarters · filed 2023-11-09 | $8.44M derived: sum of 3 quarters · filed 2023-11-09 | |
| 2022-06-30 | $2.90M 10-Q · filed 2023-11-09 | $5.55M derived: sum of 2 quarters · filed 2023-11-09 | ||
| 2022-03-31 | $2.65M 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $7.58M 10-K · filed 2023-03-06 | |||
| 2021-09-30 | $2.01M 10-Q · filed 2022-11-07 | $3.42M derived: sum of 2 quarters · filed 2022-11-07 | $4.66M derived: sum of 3 quarters · filed 2022-11-07 | |
| 2021-06-30 | $1.41M 10-Q · filed 2022-11-07 | $2.65M derived: sum of 2 quarters · filed 2022-11-07 | ||
| 2021-03-31 | $1.24M 10-Q · filed 2022-11-07 | |||
| 2020-12-31 | $4.18M 10-K · filed 2022-03-08 | |||
| 2020-09-30 | $1.24M 10-Q · filed 2021-11-10 | $2.33M derived: sum of 2 quarters · filed 2021-11-10 | $2.95M derived: sum of 3 quarters · filed 2021-11-10 | |
| 2020-06-30 | $1.08M 10-Q · filed 2021-11-10 | $1.71M derived: sum of 2 quarters · filed 2021-11-10 | ||
| 2020-03-31 | $623.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |